Clinical Trial Update: ESR-15-11293 - Saxa/Dapa, Safety and Efficacy Study [NA]

View source ↗

Summary

Clinical trial update for ESR-15-11293 (Saxa/Dapa) evaluating safety and efficacy in type 2 diabetes; trial completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapa (Dapagliflozin)
• Saxa (Saxagliptin)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Diabetes Mellitus, Type 2 | NA | Status: COMPLETED | Results posted: 2019-08-14